Evidence map›Paper›PMID 30542538›Full record

ArticleChemical science2018

Bright insights into palladium-triggered local chemotherapy.

Thomas L Bray, Mark Salji, Alessandro Brombin, Ana M Pérez-López, Belén Rubio-Ruiz, Laura C A Galbraith, E Elizabeth Patton, Hing Y Leung, Asier Unciti-Broceta

Open access · diamondAbstract read
In one paragraph

Article in Chemical science, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
8.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 98 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Modular Fabrication of Bioorthogonal Nanozymes for Biomedical Applications.Advanced materials (Deerfield Beach, Fla.) · 2024
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Nano letters · 2023
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 3 countries.

Thomas L BrayCancer Research UK Edinburgh Centre , Institute of Genetics and Molecular Medicine , University of Edinburgh , Crewe Road South , Edinburgh EH4 2XR , UK . Email: Asier.Unciti-Broceta@igmm.ed.ac.uk.
Mark SaljiInstitute of Cancer Sciences , University of Glasgow , Bearsden , Glasgow G61 1QH , UK . Email: Hing.Leung@glasgow.ac.uk.ORCID 0000-0003-4261-3086
Alessandro BrombinCancer Research UK Edinburgh Centre , Institute of Genetics and Molecular Medicine , University of Edinburgh , Crewe Road South , Edinburgh EH4 2XR , UK . Email: Asier.Unciti-Broceta@igmm.ed.ac.uk.ORCID 0000-0001-8262-9248
Ana M Pérez-LópezCancer Research UK Edinburgh Centre , Institute of Genetics and Molecular Medicine , University of Edinburgh , Crewe Road South , Edinburgh EH4 2XR , UK . Email: Asier.Unciti-Broceta@igmm.ed.ac.uk.ORCID 0000-0002-3900-3335
Belén Rubio-RuizCancer Research UK Edinburgh Centre , Institute of Genetics and Molecular Medicine , University of Edinburgh , Crewe Road South , Edinburgh EH4 2XR , UK . Email: Asier.Unciti-Broceta@igmm.ed.ac.uk.ORCID 0000-0003-4720-6578
Laura C A GalbraithInstitute of Cancer Sciences , University of Glasgow , Bearsden , Glasgow G61 1QH , UK . Email: Hing.Leung@glasgow.ac.uk.
E Elizabeth PattonCancer Research UK Edinburgh Centre , Institute of Genetics and Molecular Medicine , University of Edinburgh , Crewe Road South , Edinburgh EH4 2XR , UK . Email: Asier.Unciti-Broceta@igmm.ed.ac.uk.
Hing Y LeungInstitute of Cancer Sciences , University of Glasgow , Bearsden , Glasgow G61 1QH , UK . Email: Hing.Leung@glasgow.ac.uk.ORCID 0000-0002-3933-3975
Asier Unciti-BrocetaCancer Research UK Edinburgh Centre , Institute of Genetics and Molecular Medicine , University of Edinburgh , Crewe Road South , Edinburgh EH4 2XR , UK . Email: Asier.Unciti-Broceta@igmm.ed.ac.uk.ORCID 0000-0003-1029-2855
Edinburgh Cancer Research · GBInstitute of Cancer Research · CA

Funding

Cancer Research UK 22904Medical Research Council MC_PC_U127585840Medical Research Council MC_UU_00007/9Medical Research Council MR/L017997/1
6 · The paper itself

Abstract

The incorporation of transition metal catalysts to the bioorthogonal toolbox has opened the possibility of producing supra-stoichiometric amounts of xenobiotics in living systems in a non-enzymatic fashion. For medical use, such metals could be embedded in implantable devices (

Identifiers

PMID30542538
PMCPMC6237126
OpenAlexW2884819324

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.